Cargando…
Clinical efficacy of the over-the-scope clip device: A systematic review
BACKGROUND: The over-the-scope clip (OTSC) system has been increasingly utilized as a non-surgical option to endoscopically manage refractory gastrointestinal (GI) hemorrhage, perforations/luminal defects and fistulas. Limited data exist evaluating the efficacy and safety of OTSC. AIM: To determine...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327783/ https://www.ncbi.nlm.nih.gov/pubmed/32655272 http://dx.doi.org/10.3748/wjg.v26.i24.3495 |
_version_ | 1783552613666521088 |
---|---|
author | Bartell, Nicholas Bittner, Krystle Kaul, Vivek Kothari, Truptesh H Kothari, Shivangi |
author_facet | Bartell, Nicholas Bittner, Krystle Kaul, Vivek Kothari, Truptesh H Kothari, Shivangi |
author_sort | Bartell, Nicholas |
collection | PubMed |
description | BACKGROUND: The over-the-scope clip (OTSC) system has been increasingly utilized as a non-surgical option to endoscopically manage refractory gastrointestinal (GI) hemorrhage, perforations/luminal defects and fistulas. Limited data exist evaluating the efficacy and safety of OTSC. AIM: To determine the clinical success and adverse event (AE) rates of OTSC across all GI indications. METHODS: A PubMed search was conducted for eligible articles describing the application of the OTSC system for any indication in the GI tract. Any article or case series reporting data for less than 5 total patients was excluded. The primary outcome was the rate of clinical success. Secondary outcomes included: Technical success rate, OTSC-related AE rate and requirement for surgical intervention despite-OTSC placement. Pooled rates (per-indication and overall) were calculated as the number of patients with the event of interest divided by the total number of patients. RESULTS: A total of 85 articles met our inclusion criteria (n = 3025 patients). OTSC was successfully deployed in 94.4% of patients (n = 2856/3025). The overall rate of clinical success (all indications) was 78.4% (n = 2371/3025). Per-indication clinical success rates were as follows: (1) 86.0% (1120/1303) for GI hemorrhage; (2) 85.3% (399/468) for perforation; (3) 55.8% (347/622) for fistulae; (4) 72.6% (284/391) for anastomotic leaks; (5) 92.8% (205/221) for defect closure following endoscopic resection (e.g., following endoscopic mucosal resection or endoscopic submucosal dissection); and (6) 80.0% (16/20) for stent fixation. AE’s related to the deployment of OTSC were only reported in 64 of 85 studies (n = 1942 patients), with an overall AE rate of 2.1% (n = 40/1942). Salvage surgical intervention was required in 4.7% of patients (n = 143/3025). CONCLUSION: This systematic review demonstrates that the OTSC system is a safe and effective endoscopic therapy to manage GI hemorrhage, perforations, anastomotic leaks, defects created by endoscopic resections and for stent fixation. Clinical success in fistula management appears limited. Further studies, including randomized controlled trials comparing OTSC with conventional and/or surgical therapies, are needed to determine which indication(s) are the most effective for its use. |
format | Online Article Text |
id | pubmed-7327783 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-73277832020-07-09 Clinical efficacy of the over-the-scope clip device: A systematic review Bartell, Nicholas Bittner, Krystle Kaul, Vivek Kothari, Truptesh H Kothari, Shivangi World J Gastroenterol Systematic Reviews BACKGROUND: The over-the-scope clip (OTSC) system has been increasingly utilized as a non-surgical option to endoscopically manage refractory gastrointestinal (GI) hemorrhage, perforations/luminal defects and fistulas. Limited data exist evaluating the efficacy and safety of OTSC. AIM: To determine the clinical success and adverse event (AE) rates of OTSC across all GI indications. METHODS: A PubMed search was conducted for eligible articles describing the application of the OTSC system for any indication in the GI tract. Any article or case series reporting data for less than 5 total patients was excluded. The primary outcome was the rate of clinical success. Secondary outcomes included: Technical success rate, OTSC-related AE rate and requirement for surgical intervention despite-OTSC placement. Pooled rates (per-indication and overall) were calculated as the number of patients with the event of interest divided by the total number of patients. RESULTS: A total of 85 articles met our inclusion criteria (n = 3025 patients). OTSC was successfully deployed in 94.4% of patients (n = 2856/3025). The overall rate of clinical success (all indications) was 78.4% (n = 2371/3025). Per-indication clinical success rates were as follows: (1) 86.0% (1120/1303) for GI hemorrhage; (2) 85.3% (399/468) for perforation; (3) 55.8% (347/622) for fistulae; (4) 72.6% (284/391) for anastomotic leaks; (5) 92.8% (205/221) for defect closure following endoscopic resection (e.g., following endoscopic mucosal resection or endoscopic submucosal dissection); and (6) 80.0% (16/20) for stent fixation. AE’s related to the deployment of OTSC were only reported in 64 of 85 studies (n = 1942 patients), with an overall AE rate of 2.1% (n = 40/1942). Salvage surgical intervention was required in 4.7% of patients (n = 143/3025). CONCLUSION: This systematic review demonstrates that the OTSC system is a safe and effective endoscopic therapy to manage GI hemorrhage, perforations, anastomotic leaks, defects created by endoscopic resections and for stent fixation. Clinical success in fistula management appears limited. Further studies, including randomized controlled trials comparing OTSC with conventional and/or surgical therapies, are needed to determine which indication(s) are the most effective for its use. Baishideng Publishing Group Inc 2020-06-28 2020-06-28 /pmc/articles/PMC7327783/ /pubmed/32655272 http://dx.doi.org/10.3748/wjg.v26.i24.3495 Text en ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. |
spellingShingle | Systematic Reviews Bartell, Nicholas Bittner, Krystle Kaul, Vivek Kothari, Truptesh H Kothari, Shivangi Clinical efficacy of the over-the-scope clip device: A systematic review |
title | Clinical efficacy of the over-the-scope clip device: A systematic review |
title_full | Clinical efficacy of the over-the-scope clip device: A systematic review |
title_fullStr | Clinical efficacy of the over-the-scope clip device: A systematic review |
title_full_unstemmed | Clinical efficacy of the over-the-scope clip device: A systematic review |
title_short | Clinical efficacy of the over-the-scope clip device: A systematic review |
title_sort | clinical efficacy of the over-the-scope clip device: a systematic review |
topic | Systematic Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327783/ https://www.ncbi.nlm.nih.gov/pubmed/32655272 http://dx.doi.org/10.3748/wjg.v26.i24.3495 |
work_keys_str_mv | AT bartellnicholas clinicalefficacyoftheoverthescopeclipdeviceasystematicreview AT bittnerkrystle clinicalefficacyoftheoverthescopeclipdeviceasystematicreview AT kaulvivek clinicalefficacyoftheoverthescopeclipdeviceasystematicreview AT kotharitrupteshh clinicalefficacyoftheoverthescopeclipdeviceasystematicreview AT kotharishivangi clinicalefficacyoftheoverthescopeclipdeviceasystematicreview |